Skip to main content
    B

    Bioatla Inc (BCAB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.99
    +0.43 (+27.56%)

    Market Cap: $2.89M

    Last updated: Nov 16, 2026 at 4:00 PM ET

    Bioatla Inc (BCAB) Statistics

    Updated Nov 16, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Bioatla (BCAB) has a market cap of $2.89M and an enterprise value of $2.31M. It kept -269.41% of revenue as net income over the last 12 months. Its share count is up 41.81% from a year earlier.

    Total Valuation

    Enterprise value is 19.93% below the market cap, as cash exceeds debt.

    Market Cap$2.89M
    Enterprise Value$2.31M
    Close (Nov 16, 2026)$1.99

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateAug 6, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.34% in the quarter ended Sep 30, 2026 and shrank 81.43% a year over 2 years.

    Shares Outstanding1.67M
    Shares Change (YoY)+41.81%
    Shares Change (QoQ)+0.34%
    Share Count Growth (2Y CAGR)-81.43%

    Price Statistics

    The stock is down 93.97% over 52 weeks and trades 22.09% above its 50-day average.

    Beta (1Y)0.26
    52-Week Change-93.97%
    1-Month Change+46.32%
    3-Month Change-37.42%
    6-Month Change-49.23%
    5-Year Change-99.86%
    Total Return (1Y)-93.97%
    Total Return (3Y CAGR)-71.01%
    Total Return (5Y CAGR)-72.98%
    Return vs SPY (1Y)-108.30%
    Max Drawdown (1Y)-98.23%
    Max Drawdown (3Y)-99.45%
    Sharpe Ratio (1Y)-2.12
    Correlation with SPY (1Y)0.02
    50-Day Average$1.63
    200-Day Average$4.30
    52-Week Range$1.07 to $71.50
    RSI (14 Days)55.5
    Average Volume (20 Days)6.73K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.05x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio0.05x
    Quick Ratio0.05x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on Assets (ROA)-2125.61%
    ROIC (5Y Average)131.96%
    Asset Turnover1.03x
    Receivables Turnover8.75x

    Scores

    BCAB has an Altman Z-Score of -790.13, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Altman Z-Score-790.13
    Altman Z ZoneDistress
    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $8.75M over the last 12 months.

    Revenue$8.75M
    Gross Profit$8.75M
    Operating Income-$26.69M
    Pretax Income-$23.54M
    Net Income-$23.57M
    Reported EPS (TTM)-$17.89

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$576.00K
    Total Debt$0
    Net Cash$576.00K
    Net Cash Per Share$0.35
    Working Capital-$19.75M
    Shareholder Equity-$43.60M
    Total Assets$1.11M
    Total Liabilities$44.70M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$14.57M
    FCF Per Share-$8.74

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -305.04%.

    Gross Margin100.00%
    Operating Margin-305.04%
    Pretax Margin-269.02%
    Net Margin-269.41%

    Dividends and Yields

    BCAB does not pay a dividend.

    Buyback Yield-14.14%
    Shareholder Yield-14.14%

    Stock Splits

    The last split was a 1-for-50 reverse split on Apr 6, 2026.

    Last Split DateApr 6, 2026
    Split TypeReverse split
    Split Ratio1:50

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About BCAB

    What is BCAB's market cap?

    Bioatla has a market cap of $2.89M. Its enterprise value, which adds debt and subtracts cash, is $2.31M.

    How many shares of BCAB are outstanding?

    Bioatla has 1.67M shares outstanding. The count is up 41.81% from a year earlier.

    Does BCAB pay a dividend?

    No. Bioatla does not pay a dividend.

    How much debt does BCAB have?

    Bioatla has $0 of total debt and $576.00K of cash and equivalents, a net cash position of $576.00K.